menu search

Turning point therapeutics stock more than doubles after bristol myers buyout deal valuing company at $3.8 billion

Shares of Turning Point Therapeutics Inc. TPTX, +2.21% more than doubled, up 116.7%, in premarket trading Friday, after the clinical-stage oncology co...

June 3, 2022, 7:14 am

Oric pharmaceuticals to present at the jefferies healthcare conference

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- ORIC pharmaceuticals, Inc....

June 2, 2022, 4:10 pm

What's going on with tonix pharmaceuticals shares today?

Tonix pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower by 6.03% to $2.96 during Thu...

June 2, 2022, 8:33 am

Pieris pharmaceuticals to present at jefferies healthcare conference

BOSTON, MA / ACCESSWIRE / June 2, 2022 / Pieris pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage b...

June 2, 2022, 8:00 am

Regeneron to pay sanofi up to $1.1 billion plus royalties for its stake in libtayo collaboration

Regeneron pharmaceuticals Inc. REGN, -0.88% announced Thursday an agreement in which it will pay up to ...

June 2, 2022, 7:50 am

Spectrum pharmaceuticals to participate in two upcoming investor conferences

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum pharmaceuticals (NasdaqGS: SPPI), a bio...

June 2, 2022, 7:00 am

Nuvalent to present at the 2022 jefferies healthcare conference

CAMBRIDGE, Mass. , June 2, 2022 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceuti...

June 2, 2022, 6:38 am

Casi pharmaceuticals stock falls after reverse split takes effect

Shares of CASI pharmaceuticals Inc. CASI, +18.01% are actually falling in premarket trading Thursday, a...

June 2, 2022, 6:34 am

Sage therapeutics to present at upcoming june investor conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company ...

June 2, 2022, 6:30 am

Down 24% in a month, will arvinas stock rebound?

The stock price of Arvinas (NASDAQ: ARVN), a biopharmaceuticals company focused on oncology treatments ...

June 2, 2022, 6:00 am

Alexandria real estate: pharma's trusted landlord

Alexandria Real Estate Equities is the longest tenured owner, operator, and developer of research-oriented facilities in key cluster markets. The REIT...

June 2, 2022, 3:25 am

Why shares of amarin corporation dropped 46.1% in may

The biopharmaceutical company's lowered revenue is scaring off investors....

June 1, 2022, 7:08 pm

Xenon pharmaceuticals to present at the 2022 jefferies healthcare conference

BURNABY, British Columbia, June 01, 2022 (GLOBE NEWSWIRE) -- Xenon pharmaceuticals Inc. (Nasdaq:XENE), ...

June 1, 2022, 4:01 pm

Why tonix pharmaceuticals stock is soaring

Tonix pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading higher Wednesday after the company...

June 1, 2022, 9:08 am

Zynerba pharmaceuticals presents data on zygel cbd gel at american society of clinical psychopharmacology event this week

Zynerba pharmaceuticals (NASDAQ:ZYNE) Inc said it will deliver oral and poster presentations on its CBD...

June 1, 2022, 9:02 am

Kalvista pharmaceuticals to present at 13th annual jefferies healthcare conference

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista pharmaceuticals, Inc. (NASDA...

June 1, 2022, 6:45 am

Amerisourcebergen sets $1 billion stock buyback program

AmerisourceBergen Corp. ABC, -1.32% said Wednesday that it set a new $1 billion stock repurchase program. That represents 3.1% of the ...

June 1, 2022, 6:39 am

Agilent (a) to attract biopharma customers with apc tie-up

Agilent (A) collaborates with APC Ltd. to combine their technologies and develop unique workflows to cater to the needs of customers in the bio...

May 31, 2022, 4:34 pm

Arcus biosciences to participate in the goldman sachs 43rd annual global healthcare conference

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical...

May 31, 2022, 4:05 pm

Fda accepts regeneron, sanofi's filing for review in skin disease

The U.S. Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application (sBLA) for review submitted by Regeneron ...

May 31, 2022, 12:04 pm


Search within

Pages Search Results: